Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

ACE2, a new regulator of the renin-angiotensin system.

Burrell LM, Johnston CI, Tikellis C, Cooper ME.

Trends Endocrinol Metab. 2004 May-Jun;15(4):166-9. Review.

PMID:
15109615
2.

[The importance of ACE2 in regulating the cardiovascular system].

Raz A, Gamliel-Lazarovich A, Bogner I, Strigevsky A, Keidar S.

Harefuah. 2007 Sep;146(9):703-6, 733. Review. Hebrew.

PMID:
17969309
3.

Angiotensin-converting enzyme II in the heart and the kidney.

Danilczyk U, Penninger JM.

Circ Res. 2006 Mar 3;98(4):463-71. Review.

4.

ACE2 and diabetic complications.

Dean RG, Burrell LM.

Curr Pharm Des. 2007;13(26):2730-5. Review.

PMID:
17897017
5.

The role of ACE2 in cardiovascular physiology.

Oudit GY, Crackower MA, Backx PH, Penninger JM.

Trends Cardiovasc Med. 2003 Apr;13(3):93-101. Review.

PMID:
12691672
6.

Angiotensin-converting enzyme 2: possible role in hypertension and kidney disease.

Wysocki J, González-Pacheco FR, Batlle D.

Curr Hypertens Rep. 2008 Feb;10(1):70-7. Review.

PMID:
18367030
7.

Physiological roles of angiotensin-converting enzyme 2.

Danilczyk U, Eriksson U, Oudit GY, Penninger JM.

Cell Mol Life Sci. 2004 Nov;61(21):2714-9. Review.

PMID:
15549172
8.

The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases.

Lazartigues E, Feng Y, Lavoie JL.

Curr Pharm Des. 2007;13(12):1231-45. Review.

PMID:
17504232
9.

Not just angiotensinases: new roles for the angiotensin-converting enzymes.

Lambert DW, Clarke NE, Turner AJ.

Cell Mol Life Sci. 2010 Jan;67(1):89-98. doi: 10.1007/s00018-009-0152-x. Epub 2009 Sep 10. Review.

PMID:
19763395
10.

Angiotensin converting enzyme 2 in the kidney.

Koitka A, Cooper ME, Thomas MC, Tikellis C.

Clin Exp Pharmacol Physiol. 2008 Apr;35(4):420-5. doi: 10.1111/j.1440-1681.2008.04889.x. Review.

PMID:
18307733
12.

Angiotensin-converting enzyme 2 and the kidney.

Soler MJ, Wysocki J, Batlle D.

Exp Physiol. 2008 May;93(5):549-56. doi: 10.1113/expphysiol.2007.041350. Epub 2008 Jan 25. Review.

13.
14.

ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.

Mendoza-Torres E, Oyarzún A, Mondaca-Ruff D, Azocar A, Castro PF, Jalil JE, Chiong M, Lavandero S, Ocaranza MP.

Ther Adv Cardiovasc Dis. 2015 Aug;9(4):217-37. doi: 10.1177/1753944715597623. Epub 2015 Aug 13. Review.

PMID:
26275770
15.

The emerging role of ACE2 in physiology and disease.

Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, Timens W, Turner AJ, Navis G, van Goor H.

J Pathol. 2007 May;212(1):1-11. Review.

PMID:
17464936
16.

Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.

Kurdi M, De Mello WC, Booz GW.

Int J Biochem Cell Biol. 2005 Jul;37(7):1357-67. Review.

PMID:
15833268
17.

Angiotensin-converting enzyme-2: a molecular and cellular perspective.

Warner FJ, Smith AI, Hooper NM, Turner AJ.

Cell Mol Life Sci. 2004 Nov;61(21):2704-13. Review.

PMID:
15549171
18.

Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system.

Lambert DW, Hooper NM, Turner AJ.

Biochem Pharmacol. 2008 Feb 15;75(4):781-6. Epub 2007 Aug 17. Review.

PMID:
17897633
19.

Angiotensin-converting enzyme 2 in acute respiratory distress syndrome.

Imai Y, Kuba K, Penninger JM.

Cell Mol Life Sci. 2007 Aug;64(15):2006-12. Review.

PMID:
17558469
20.

The physiological significance of the alternative pathways of angiotensin II production.

Kramkowski K, Mogielnicki A, Buczko W.

J Physiol Pharmacol. 2006 Dec;57(4):529-39. Review.

Supplemental Content

Support Center